Development of multifunctional heterocyclic Schiff base as a potential metal chelator: a comprehensive spectroscopic approach towards drug discovery

No abstract is available for this paper.

• Publication year

  2016

• Venue

  JBIC Journal of Biological Inorganic Chemistry

• Publication date

  Unknown publication date

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1007/s00775-016-1407-2PMID 27822620
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Amyloid- Receptors: The Good, the Bad, and the Prion Protein*

  2016cited by this paper
• Effect of Copper and Zinc on the Single Molecule Self-Affinity of Alzheimer’s Amyloid-β Peptides

  2016cited by this paper
• P1‐146: Chlamydia Pneumoniae‐Infected Astrocytes Alter Their Expression of Adam10, Bace1, and Presenilin‐1 Proteases

  2016cited by this paper
• 2016 Alzheimer's disease facts and figures

  2016cited by this paper
• Alzheimer's Disease: A Heme-Aβ Perspective.

  2015cited by this paper
• Surfactant induced aggregation–disaggregation of photodynamic active chlorin e6 and its relevant interaction with DNA alkylating quinone in a biomimic micellar microenvironment

  2015cited by this paper
• Multifunctional 3-Schiff base-4-hydroxycoumarin derivatives with monoamine oxidase inhibition, anti-β-amyloid aggregation, metal chelation, antioxidant and neuroprotection properties against Alzheimer's disease

  2015cited by this paper
• Effect of Metals on Kinetic Pathways of Amyloid-β Aggregation

  2014cited by this paper
• β-Amyloid Fibrils in Alzheimer Disease Are Not Inert When Bound to Copper Ions but Can Degrade Hydrogen Peroxide and Generate Reactive Oxygen Species*

  2014cited by this paper
• Modulation of Amyloid‐β Aggregation by Histidine‐Coordinating Cobalt(III) Schiff Base Complexes

  2014cited by this paper
• Small Bifunctional Chelators That Do Not Disaggregate Amyloid β Fibrils Exhibit Reduced Cellular Toxicity

  2014cited by this paper
• Self-assembly of stable oligomeric and fibrillar aggregates of Aβ peptides relevant to Alzheimer's disease: morphology dependent Cu/heme toxicity and inhibition of PROS generation.

  2014cited by this paper
• Rational design of a structural framework with potential use to develop chemical reagents that target and modulate multiple facets of Alzheimer's disease.

  2014cited by this paper
• 3-Hydroxy-4-pyridinone derivatives as metal ion and amyloid binding agents.

  2014cited by this paper
• Testing synthetic amyloid-β aggregation inhibitor using single molecule atomic force spectroscopy.

  2014cited by this paper
• Recent advances in the multitarget‐directed ligands approach for the treatment of Alzheimer's disease

  2013cited by this paper
• Effects of Zn2+ binding on the structural and dynamic properties of amyloid β peptide associated with Alzheimer's disease: Asp1 or Glu11?

  2013cited by this paper
• Bioinorganic chemistry of Alzheimer's disease.

  2012cited by this paper
• Liberation of copper from amyloid plaques: making a risk factor useful for Alzheimer's disease treatment.

  2012cited by this paper
• Effects of Ligands on Unfolding of the Amyloid β-Peptide Central Helix: Mechanistic Insights from Molecular Dynamics Simulations

  2012cited by this paper
• Bifunctional compounds for controlling metal-mediated aggregation of the aβ42 peptide.

  2012cited by this paper
• Metal binding sites in amyloid oligomers: Complexes and mechanisms

  2012cited by this paper
• Molecular Mechanisms of Amyloid Oligomers Toxicity

  2012cited by this paper
• Role of metal dyshomeostasis in Alzheimer's disease.

  2011cited by this paper
• Development of bifunctional stilbene derivatives for targeting and modulating metal-amyloid-β species.

  2011cited by this paper
• FoldAmyloid: a method of prediction of amyloidogenic regions from protein sequence

  2010cited by this paper
• Design of small molecules that target metal-Aβ species and regulate metal-induced Aβ aggregation and neurotoxicity

  2010cited by this paper
• Revising the definition of Alzheimer's disease: a new lexicon.

  2010cited by this paper
• Electrochemical and homogeneous electron transfers to the Alzheimer amyloid-β copper complex follow a preorganization mechanism

  2010cited by this paper
• Design, selection, and characterization of thioflavin-based intercalation compounds with metal chelating properties for application in Alzheimer's disease.

  2009cited by this paper
• Small molecule modulators of copper-induced Abeta aggregation.

  2009cited by this paper
• The chemistry of Alzheimer's disease.

  2009cited by this paper
• Protein aggregation probed by two-photon fluorescence correlation spectroscopy of native tryptophan.

  2008cited by this paper
• Multi-target-directed ligands to combat neurodegenerative diseases.

  2008cited by this paper
• Benchmarking the reliability of QikProp. Correlation between experimental and predicted values

  2008cited by this paper
• Rare example of mu-nitrito-1kappa2O,O':2kappaO coordinating mode in copper(II) nitrite complexes with monoanionic tridentate Schiff base ligands: structure, magnetic, and electrochemical properties.

  2008cited by this paper
• Detecting amyloid-beta aggregation with fiber-based fluorescence correlation spectroscopy.

  2007cited by this paper
• Detecting Amyloid-β Aggregation with Fiber-Based Fluorescence Correlation Spectroscopy

  2007cited by this paper
• Hydroxyl radical-mediated modification of proteins as probes for structural proteomics.

  2007cited by this paper
• Molecular dynamics study of the beta amyloid peptide of Alzheimer's disease and its divalent copper complexes.

  2007cited by this paper
• Mechanism of thioflavin T accumulation inside cells overexpressing P-glycoprotein or multidrug resistance-associated protein: role of lipophilicity and positive charge.

  2006cited by this paper
• Drug resistance in brain diseases and the role of drug efflux transporters

  2005cited by this paper
• Blood-brain barrier active efflux transporters: ATP-binding cassette gene family

  2005cited by this paper
• Conformational transition of amyloid β-peptide

  2005cited by this paper
• Conformational transition of amyloid beta-peptide.

  2005cited by this paper
• In vivo optical imaging of amyloid aggregates in brain: design of fluorescent markers.

  2005cited by this paper
• In vitro and in vivo antimalarial activity of peptidomimetic protein farnesyltransferase inhibitors with improved membrane permeability.

  2004cited by this paper
• Glide: a new approach for rapid, accurate docking and scoring. 2. Enrichment factors in database screening.

  2004cited by this paper
• ABC transporters and the blood-brain barrier.

  2004cited by this paper
• Oxidative DNA damage: mechanisms, mutation, and disease

  2003cited by this paper
• The Amyloid β Peptide (Aβ1-40) Is Thermodynamically Soluble at Physiological Concentrations†

  2003cited by this paper
• The amyloid beta peptide (Abeta(1-40)) is thermodynamically soluble at physiological concentrations.

  2003cited by this paper
• A lipophilic thioflavin-T derivative for positron emission tomography (PET) imaging of amyloid in brain.

  2002cited by this paper
• Measuring diffusion in cell membranes by fluorescence correlation spectroscopy.

  2002cited by this paper
• Oxidative stress and Alzheimer disease.

  2000cited by this paper
• Amyloid, prions, and other protein aggregates

  2000cited by this paper
• Cu(II) potentiation of alzheimer abeta neurotoxicity. Correlation with cell-free hydrogen peroxide production and metal reduction.

  1999cited by this paper
• Amyloid, prions, and other protein aggregates

  1999cited by this paper
• The A beta peptide of Alzheimer's disease directly produces hydrogen peroxide through metal ion reduction.

  1999cited by this paper
• Quantification of beta-sheet amyloid fibril structures with thioflavin T.

  1999cited by this paper
• Copper, iron and zinc in Alzheimer's disease senile plaques.

  1998cited by this paper
• beta-Amyloid-associated free radical oxidative stress and neurotoxicity: implications for Alzheimer's disease.

  1997cited by this paper
• Prolines and amyloidogenicity in fragments of the Alzheimer's peptide beta/A4.

  1995cited by this paper
• Structure of amyloid A4-(1-40)-peptide of Alzheimer's disease.

  1995cited by this paper
• Alzheimer's disease: the amyloid cascade hypothesis.

  1992cited by this paper
• Isomeric complexes of ruthenium(II) with neutral heterocyclic schiff base ligands. High resolution proton resonance spectra of trans-cis isomeric pairs of RuX2L2 (L 2-arylpyridinecarboxaldimine, X Cl, Br) and comparison of their physical properties

  1992cited by this paper
• Synthetic peptide homologous to beta protein from Alzheimer disease forms amyloid-like fibrils in vitro.

  1987cited by this paper
• Amyloid plaque core protein in Alzheimer disease and Down syndrome.

  1985cited by this paper
• Lipid peroxidation initiated by superoxide‐dependent hydroxyl radicals using complexed iron and hydrogen peroxide

  1984cited by this paper
• Principles of fluorescence spectroscopy

  1983cited by this paper
• Production of formaldehyde during metabolism of dimethyl sulfoxide by hydroxyl radical generating systems.

  1981cited by this paper
• Selective loss of central cholinergic neurons in Alzheimer's disease.

  1976cited by this paper

• Binding copper(II) ion released from azo-amino acid Schiff base complex into lysozyme crystals as models for treatment of Alzheimer’s disease

  2025cites this paper
• Identifying and harnessing ESIPT properties of a strategically designed bichromophoric coumarin-benzothiazole Schiff’s base for opto-chemical information processing applications

  2025cites this paper
• Antioxidant activity at the molecular level: exploring ways of action and computational tools to investigate them

  2025cites this paper
• Investigating PFOS-induced structural changes and aggregation in hen egg white lysozyme: spectroscopic and molecular insights.

  2025cites this paper
• Design, synthesis and evaluation of aminothiazole derivatives as potential anti-Alzheimer's candidates.

  2024cites this paper
• Azomethine-functionalized organic–inorganic framework: an overview

  2023cites this paper
• Novel Pd(ii) pincer complexes bearing salicylaldimine-based benzothiazole derivatives: synthesis, structural characterization, DNA/BSA binding, and biological evaluation

  2023cites this paper
• Probing the interaction and aggregation of lysozyme in presence of organophosphate pesticides: a comprehensive spectroscopic, calorimetric, and in-silico investigation

  2023cites this paper
• Effect of artificial sweetener saccharin on lysozyme aggregation: A combined spectroscopic and in silico approach.

  2022cites this paper
• Biological Activities of Schiff Bases Incorporating Benzothiazole Moiety

  2022cites this paper
• Unraveling the Pharmaceutical Benefits of Freshly Prepared Amino Acid-Based Schiff Bases Via DFT, In Silico Molecular Docking and ADMET

  2022cites this paper
• Novel Benzothiazole-Based Highly Selective Ratiometric Fluorescent Turn-On Sensors for Zn2+ and Colorimetric Chemosensors for Zn2+, Cu2+, and Ni2+ Ions

  2021cites this paper
• Design, synthesis and biological evaluation of Schiff’s base derivatives as multifunctional agents for the treatment of Alzheimer’s disease

  2020cites this paper
• New tailored substituted benzothiazole Schiff base Cu(II)/Zn(II) antitumor drug entities: effect of substituents on DNA binding profile, antimicrobial and cytotoxic activity

  2019cites this paper